Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study

To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center.

Detalles Bibliográficos
Autores principales: Khodadadi, Kasra, Moghimi, Minoosh, Mansouri, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576967/
https://www.ncbi.nlm.nih.gov/pubmed/36267821
http://dx.doi.org/10.1002/ccr3.6392
_version_ 1784811649114308608
author Khodadadi, Kasra
Moghimi, Minoosh
Mansouri, Reza
author_facet Khodadadi, Kasra
Moghimi, Minoosh
Mansouri, Reza
author_sort Khodadadi, Kasra
collection PubMed
description To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center.
format Online
Article
Text
id pubmed-9576967
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95769672022-10-19 Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study Khodadadi, Kasra Moghimi, Minoosh Mansouri, Reza Clin Case Rep Case Report To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center. John Wiley and Sons Inc. 2022-10-17 /pmc/articles/PMC9576967/ /pubmed/36267821 http://dx.doi.org/10.1002/ccr3.6392 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Khodadadi, Kasra
Moghimi, Minoosh
Mansouri, Reza
Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study
title Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study
title_full Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study
title_fullStr Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study
title_full_unstemmed Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study
title_short Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study
title_sort cancer patients and targeted therapy during covid‐19 pandemic: a descriptive case series study
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576967/
https://www.ncbi.nlm.nih.gov/pubmed/36267821
http://dx.doi.org/10.1002/ccr3.6392
work_keys_str_mv AT khodadadikasra cancerpatientsandtargetedtherapyduringcovid19pandemicadescriptivecaseseriesstudy
AT moghimiminoosh cancerpatientsandtargetedtherapyduringcovid19pandemicadescriptivecaseseriesstudy
AT mansourireza cancerpatientsandtargetedtherapyduringcovid19pandemicadescriptivecaseseriesstudy

Ejemplares similares